Cover Image

The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial

Background: Despite advancements in chronic heart failure (CHF) treatment, the effect often remains unsatisfactory and unstable. More effective therapies are needed. Qishen granules (QSG) are a novel Chinese botanical drug effective in treating CHF in animal models, but clinical evidence remains ina...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kangjia Du (Author), Junjie Liu (Author), Nannan Tan (Author), Xinyi Huang (Author), Juan Wang (Author), Huihui Zhao (Author), Wei Wang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Qishen granules exerts cardioprotective effects on rats with heart failure via regulating fatty acid and glucose metabolism
by: Kuo Gao, et al.
Published: (2020)

Efficacy of Xinbao pill on chronic heart failure: Study protocol of a multicenter, randomized, double-blind, placebo-controlled trial
by: Yuanping Wang, et al.
Published: (2022)

Qishen Granule Improved Cardiac Remodeling via Balancing M1 and M2 Macrophages
by: Wenji Lu, et al.
Published: (2019)

Efficacy of Qishen Yiqi Drop Pill for Chronic Heart Failure: An Updated Meta-Analysis of 85 Studies
by: Hao Wang, et al.
Published: (2020)

Sijunzi decoction granules in the prevention and treatment of recurrence of colorectal adenoma: Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
by: Wenjing Ni, et al.
Published: (2023)

Qishen Granule (QSG) Inhibits Monocytes Released From the Spleen and Protect Myocardial Function via the TLR4-MyD88-NF-κB p65 Pathway in Heart Failure Mice
by: Yanqin Li, et al.
Published: (2022)

Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
by: Mengxi Wang, et al.
Published: (2021)

Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
by: Si-Chun Gu, et al.
Published: (2022)

URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL
by: S. von Haehling, et al.
Published: (2015)

URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL
by: S. von Haehling, et al.
Published: (2015)

Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial
by: Weinan Li, et al.
Published: (2023)

A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
by: Yingying Wan, et al.
Published: (2022)

Wangbi granule as a combination therapy to achieve clinical deep remission in rheumatoid arthritis: protocol for a multicenter, triple-blind, randomised, placebo-controlled trial
by: Jinping Wang, et al.
Published: (2023)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Loki zupa in Patients With Chronic Asthma
by: Yubao Lv, et al.
Published: (2018)

Tonghua Liyan granules in the treatment of Laryngopharyngeal reflux disease with stagnation of phlegm and qi syndrome: a randomized, double-blind, placebo-controlled study
by: Yading Li, et al.
Published: (2024)

Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis
by: Mingjun Zhu, et al.
Published: (2022)

Corrigendum: A Chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
by: Yingying Wan, et al.
Published: (2022)

Effect of Traditional Chinese Formula Dingkun Pill on Primary Dysmenorrhea: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
by: Xuesong Ding, et al.
Published: (2023)

P2X7R-NEK7-NLRP3 Inflammasome Activation: A Novel Therapeutic Pathway of Qishen Granule in the Treatment of Acute Myocardial Ischemia
by: Li Y, et al.
Published: (2022)

Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
by: Julie Schjødtz Hansen, et al.
Published: (2023)

Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol
by: Peng-Xiang Zhang, et al.
Published: (2022)

Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)
by: Marie Chevallier, et al.
Published: (2020)

A double-blind placebo needle for acupuncture research
by: Takakura Nobuari, et al.
Published: (2007)

Effect of YuPingFeng granules on clinical symptoms of stable COPD: study protocol for a multicenter, double-blind, and randomized controlled trial
by: Ruifeng Chen, et al.
Published: (2024)

Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
by: Xuedong An, et al.
Published: (2022)

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review
by: Yili Zhang, et al.
Published: (2020)

Effect of Low-Power Visible-Light-Activated Photodynamic Therapy (PDT) on Primary Dysmenorrhea: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
by: Gu B, et al.
Published: (2022)

Correction: Effect of YuPingFeng granules on clinical symptoms of stable COPD: study protocol for a multicenter, double-blind, and randomized controlled trial
by: Ruifeng Chen, et al.
Published: (2024)

Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
by: Limin Liao, et al.
Published: (2022)

Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
by: Valerie J. Ludbrook, et al.
Published: (2024)

Effect of montelukast in preventing dengue with warning signs among patients with dengue: A multicenter, randomized, double-blind, placebo-controlled trial.
by: Nattapat Nitinai, et al.
Published: (2024)

Randomized double-blind placebo-controlled multicenter trial for the effects of a polyherbal remedy, Yokukansan (YiganSan), in smokers with depressive tendencies
by: Maki Komiyama, et al.
Published: (2022)

A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
by: Haridas Upadya, et al.
Published: (2019)

Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial
by: Xuan Xu, et al.
Published: (2023)

Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial
by: Yang Li, et al.
Published: (2019)

Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial
by: Rui Fang, et al.
Published: (2023)

Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study
by: von Lindern Jeannette, et al.
Published: (2010)

Post-exposure prophylaxis of COVID-19: results of double-blind, placebo-controlled, multicenter clinical study evaluation of efficacy and safety of double-stranded sodium salt RNA drug
by: L. A. Balykova, et al.
Published: (2023)

Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial
by: Jianguo Lin, et al.
Published: (2023)

Efficacy and Safety of Suxiao Jiuxin Pills in the Treatment of Chronic Coronary Syndrome with Intolerance to Adverse Effects of Long-acting Nitrates: A Multicenter, Randomized, Double-blind, Placebo-controlled Study
by: Yuanlong Hu, et al.
Published: (2024)